Analysis Moderna’s Post-Rally Pullback Masks a Deeper Shift in Its Pipeline Story
The euphoria that lifted Moderna shares to a record high on Wednesday has given way to a sharp correction, with the stock shedding roughly a fifth of its value in...
Latest financial market updates and expert analysis
Analysis The euphoria that lifted Moderna shares to a record high on Wednesday has given way to a sharp correction, with the stock shedding roughly a fifth of its value in...
The numbers were flattering enough on their own. Voestalpine opened fiscal 2026/27 with revenue of €4.0 billion, up 2.4 percent...
The countdown to CrowdStrike’s fiscal second-quarter report has turned into a study in competing signals. On one side sit bullish...
The gap between a single trading session and a multi-year investment thesis has rarely been wider than it is right...
The Norwegian hydrogen specialist has entered a holding pattern that feels increasingly uncomfortable. With no fresh corporate announcements, contract wins,...
The gap between Microsoft’s operational momentum and its market reception has rarely been wider. The company’s cloud business is compounding...
The gap between Vonovia’s balance sheet and its stock market valuation has rarely been wider. Germany’s largest residential landlord reported...
The numbers from Tuesday’s report were, by any conventional measure, poor. Adjusted net profit of 6.2 billion yuan marked a...
Parties in Swiss civil disputes who opt for voluntary conciliation before heading to court just got a significant procedural boost....
The arithmetic at Broadcom is getting harder to reconcile. Over the past week, the shares have shed roughly 7% in...
The arithmetic of shareholder returns at Novo Nordisk tells a story of patience under pressure. The Danish drugmaker has plowed...